Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises BlackRock Renewable Finance (Dublin) Limited on its acquisition of Arise Wind Farm 10 AB
Mandate

Vinge advises BlackRock Renewable Finance (Dublin) Limited on its acquisition of Arise Wind Farm 10 AB

November 14, 2014

Vinge is advising BlackRock Renewable Finance (Dublin) Limited in connection with the acquisition of Arise Wind Farm 10 AB. The deal includes the sale of the construction-ready 46.2 MW Brotorp wind farm. Arise AB will manage the construction of the project, and once operational, operate the project on behalf of BlackRock Renewable Finance (Dublin) Limited through a construction and asset management agreement. BlackRock Renewable Finance (Dublin) Limited will provide equity to the project and a project finance facility has successfully been secured from SEB.

The Vinge team advising BlackRock Renewable Finance (Dublin) Limited includes partner Johan Göthberg and associates Gustav Jönsson and Johan Cederblad. Partner Fabian Ekeblad and associates Anders Morén and Oscar Rydén are advising on the financing of the transaction.

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

 Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

 Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025